Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAtla (BCAB) Treasury Shares (2020 - 2025)

BioAtla (BCAB) has disclosed Treasury Shares for 6 consecutive years, with $2.4 million as the latest value for Q4 2025.

  • For Q4 2025, Treasury Shares rose 56.72% year-over-year to $2.4 million; the TTM value through Dec 2025 reached $2.4 million, up 56.72%, while the annual FY2025 figure was $2.4 million, 56.72% up from the prior year.
  • Treasury Shares hit $2.4 million in Q4 2025 for BioAtla, down from $2.5 million in the prior quarter.
  • Across five years, Treasury Shares topped out at $2.9 million in Q1 2025 and bottomed at $99104.0 in Q4 2023.
  • Average Treasury Shares over 5 years is $1.3 million, with a median of $1.6 million recorded in 2024.
  • Year-over-year, Treasury Shares tumbled 80.57% in 2023 and then surged 1467.04% in 2024.
  • BioAtla's Treasury Shares stood at $975046.0 in 2021, then plummeted by 47.69% to $510039.0 in 2022, then crashed by 80.57% to $99104.0 in 2023, then soared by 1467.04% to $1.6 million in 2024, then skyrocketed by 56.72% to $2.4 million in 2025.
  • According to Business Quant data, Treasury Shares over the past three periods came in at $2.4 million, $2.5 million, and $2.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.